Link Technologies Licenses Agilent's RNA Monomers | GenomeWeb

NEW YORK (GenomeWeb News) – Link Technologies has licensed Agilent Technologies' RNA monomers technology, the Scottish company said today.

Link Technologies said it will manufacture and sell the four RNA monomer phosphoramidite reagents for use in research.

The company makes reagents for oligonucleotide synthesis and modification, and it offers a variety of products including phosphoramidites, solid supports, modifiers, labels, bioconjugation and oligo-immobilisation products.

Financial terms of the agreement were not released.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.